Lung Cancer Cell-Macrophage Interaction System for Signal Pathway-Based Logic Analysis and Drug Testing

Area of Science:

• Biomedical Engineering
• Cancer Biology
• Microfluidics

Background:

• Understanding intercellular signaling pathways is vital for cancer research and drug development.
• Current tumor research often overlooks molecular logic in signaling pathways, focusing instead on individual biomolecules.
• Interactions between lung cancer cells and macrophages involve complex signaling pathways like NF-κB.

Purpose of the Study:

• To develop an integrated microfluidic system for analyzing molecular logic in intercellular signaling pathways.
• To investigate the logical relationships between specific microRNAs and cytokines in lung cancer-macrophage interactions.
• To enable on-chip visualization of signaling pathway activation and facilitate drug testing.

Main Methods:

• Development of a microfluidic chip-based electrochemical logic analysis (μELA) system integrating lung cancer, macrophage, logic gate, and electrochemical sensing chips.
• Analysis of the logical relationship between miR-21, miR-29a, and interleukin-6 (IL-6) secreted by lung cancer cells and macrophages.
• On-chip visualization of the NF-κB signaling pathway and drug efficacy testing using the μELA system.

Main Results:

• The μELA system successfully analyzed the logical relationships between key biomarkers (miR-21, miR-29a, IL-6) and visualized NF-κB pathway activation.
• Drug testing demonstrated that combination inhibitors targeting cancer cell-macrophage interactions were more effective in inducing apoptosis than single-target inhibitors.
• The system supports in situ cell culturing, biomarker sensing, automated logic analysis, and signaling pathway-based drug screening.

Conclusions:

• The integrated μELA system provides a powerful platform for studying complex cancer signaling mechanisms.
• This approach facilitates the discovery of novel therapeutic strategies by evaluating drug combinations targeting cell-cell interactions.
• The μELA system holds significant potential for advancing cancer research and accelerating anticancer drug discovery.